PYRUKYND is the only medicine approved in the UAE for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia NewBridge Pharmaceuticals, a regional specialty company ...
Toogood Gold Corp. (TSXV: TGC) (OTCQB: TGGCF) (FSE: D3P) ("Toogood" or the "Company") today announced that it has entered into a binding Letter of Intent dated February 27, 2026 (the "LOI") with ...
Year 2025 AFFO Guidance - Reduced Net Debt by $2.2 Billion and Improved Net Debt to Adjusted EBITDA From 7.6x to 6.7x in 2025 - Repurchased 17.2 Million Shares at a Weighted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results